PA8776701A1 - Utilización de 4-ciclopropilmetoxi-n-(3,5-dicloro-1-oxido-4-piridin-4-il)-5-(metoxi)piridin-2-carboxamida para el tratamiento de los traumatismos craneales. - Google Patents
Utilización de 4-ciclopropilmetoxi-n-(3,5-dicloro-1-oxido-4-piridin-4-il)-5-(metoxi)piridin-2-carboxamida para el tratamiento de los traumatismos craneales.Info
- Publication number
- PA8776701A1 PA8776701A1 PA20088776701A PA8776701A PA8776701A1 PA 8776701 A1 PA8776701 A1 PA 8776701A1 PA 20088776701 A PA20088776701 A PA 20088776701A PA 8776701 A PA8776701 A PA 8776701A PA 8776701 A1 PA8776701 A1 PA 8776701A1
- Authority
- PA
- Panama
- Prior art keywords
- piridin
- metoxi
- dicloro
- oxido
- carboxamide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
LA INVENCION SE REFIERE A LA UTILIZACION DE 4-CICLOPROPILMETOXI-N-(3,5-DICLORO-1-OXIDO-PIRIDIN-4-IL)-5-(METOXI)PIRIDIN-2-CARBOXAMIDA PARA LA PREPARACION DE UN MEDICAMENTO DESTINADO AL TRATAMIENTO DE LOS TRAUMATISMOS CEREBRALES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0702852A FR2915099B1 (fr) | 2007-04-19 | 2007-04-19 | Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes craniens |
Publications (1)
Publication Number | Publication Date |
---|---|
PA8776701A1 true PA8776701A1 (es) | 2008-11-19 |
Family
ID=38819821
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PA20088776701A PA8776701A1 (es) | 2007-04-19 | 2008-04-15 | Utilización de 4-ciclopropilmetoxi-n-(3,5-dicloro-1-oxido-4-piridin-4-il)-5-(metoxi)piridin-2-carboxamida para el tratamiento de los traumatismos craneales. |
Country Status (34)
Country | Link |
---|---|
US (1) | US9393236B2 (es) |
EP (1) | EP2146713B1 (es) |
JP (1) | JP5386476B2 (es) |
KR (1) | KR101460828B1 (es) |
CN (1) | CN101663036B (es) |
AR (1) | AR066105A1 (es) |
AT (1) | ATE532513T1 (es) |
AU (1) | AU2008257319B2 (es) |
BR (1) | BRPI0810423A2 (es) |
CA (1) | CA2684171C (es) |
CL (1) | CL2008001135A1 (es) |
CO (1) | CO6140028A2 (es) |
CY (1) | CY1112282T1 (es) |
DK (1) | DK2146713T3 (es) |
EA (1) | EA015503B1 (es) |
ES (1) | ES2376023T3 (es) |
FR (1) | FR2915099B1 (es) |
HK (1) | HK1141724A1 (es) |
HR (1) | HRP20120130T1 (es) |
IL (1) | IL201447A (es) |
JO (1) | JO2861B1 (es) |
MA (1) | MA31368B1 (es) |
ME (2) | ME00938B (es) |
MX (1) | MX2009011214A (es) |
MY (1) | MY147207A (es) |
NZ (1) | NZ580484A (es) |
PA (1) | PA8776701A1 (es) |
PL (1) | PL2146713T3 (es) |
PT (1) | PT2146713E (es) |
RS (1) | RS52130B (es) |
SI (1) | SI2146713T1 (es) |
TW (1) | TWI423800B (es) |
UY (1) | UY31034A1 (es) |
WO (1) | WO2008145838A2 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014083107A1 (en) * | 2012-11-28 | 2014-06-05 | Sanofi | METHOD OF PREPARATION OF CRYSTAL FORMS OF 4-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLORO-1-OXIDOPYRIDYN-4-yl)-5-METHOXYPYRIDINE-2-CARBOXAMIDE AND CRISTAL FORMS THEREOF |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1273326A (en) * | 1917-08-22 | 1918-07-23 | George H Bugenhagen | Transmission mechanism. |
US4193926A (en) | 1974-03-20 | 1980-03-18 | Schering Aktiengesellschaft | 4-(Polyalkoxy phenyl)-2-pyrrolidones |
JP3775685B2 (ja) | 1993-07-28 | 2006-05-17 | ローン−プーラン・ロレ・リミテツド | Pde▲iv▼およびtnf抑制剤としての化合物 |
GB9401460D0 (en) * | 1994-01-26 | 1994-03-23 | Rhone Poulenc Rorer Ltd | Compositions of matter |
GB9507297D0 (en) * | 1995-04-07 | 1995-05-31 | Rh Ne Poulenc Rorer Limited | New composition of matter |
US6177077B1 (en) | 1999-02-24 | 2001-01-23 | Edward L. Tobinick | TNT inhibitors for the treatment of neurological disorders |
WO2000075116A2 (en) * | 1999-06-07 | 2000-12-14 | Warner-Lambert Company | Tricyclic analgesics |
ATE290002T1 (de) * | 1999-12-23 | 2005-03-15 | Icos Corp | Cyclische amp spezifische phosphodiesterase inhibitoren |
US20030069169A1 (en) | 2001-03-02 | 2003-04-10 | Macor John E. | Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-AMP associated disorders |
AU2003281219A1 (en) | 2002-07-02 | 2004-01-23 | Bernard Cote | Di-aryl-substituted-ethane pyridone pde4 inhibitors |
US20060083714A1 (en) * | 2003-01-27 | 2006-04-20 | Warner James M | Combination of a pde iv inhibitor and a tnf-alpha antagonist |
WO2005032493A2 (en) | 2003-10-07 | 2005-04-14 | Renovis, Inc. | Amide compounds as ion channel ligands and uses thereof |
US20070049611A1 (en) * | 2005-06-10 | 2007-03-01 | Talamas Francisco X | Phosphodiesterase 4 inhibitors |
US20070021451A1 (en) | 2005-07-20 | 2007-01-25 | Hamamatsu University School Of Medicine | Method for preventing or treating neurologic damage after spinal cord injury |
FR2915098B1 (fr) | 2007-04-19 | 2009-06-05 | Sanofi Aventis Sa | Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes de la moelle epiniere |
-
2007
- 2007-04-19 FR FR0702852A patent/FR2915099B1/fr not_active Expired - Fee Related
-
2008
- 2008-04-15 PA PA20088776701A patent/PA8776701A1/es unknown
- 2008-04-16 MX MX2009011214A patent/MX2009011214A/es active IP Right Grant
- 2008-04-16 AU AU2008257319A patent/AU2008257319B2/en not_active Ceased
- 2008-04-16 BR BRPI0810423-9A2A patent/BRPI0810423A2/pt not_active IP Right Cessation
- 2008-04-16 PL PL08787960T patent/PL2146713T3/pl unknown
- 2008-04-16 KR KR1020097021592A patent/KR101460828B1/ko not_active IP Right Cessation
- 2008-04-16 CN CN2008800127185A patent/CN101663036B/zh not_active Expired - Fee Related
- 2008-04-16 WO PCT/FR2008/000531 patent/WO2008145838A2/fr active Application Filing
- 2008-04-16 SI SI200830535T patent/SI2146713T1/sl unknown
- 2008-04-16 JP JP2010503546A patent/JP5386476B2/ja not_active Expired - Fee Related
- 2008-04-16 EP EP08787960A patent/EP2146713B1/fr active Active
- 2008-04-16 ME MEP-2009-306A patent/ME00938B/me unknown
- 2008-04-16 NZ NZ580484A patent/NZ580484A/en not_active IP Right Cessation
- 2008-04-16 ME MEP-2012-15A patent/ME01273B/me unknown
- 2008-04-16 AT AT08787960T patent/ATE532513T1/de active
- 2008-04-16 PT PT08787960T patent/PT2146713E/pt unknown
- 2008-04-16 ES ES08787960T patent/ES2376023T3/es active Active
- 2008-04-16 CA CA2684171A patent/CA2684171C/fr not_active Expired - Fee Related
- 2008-04-16 DK DK08787960.7T patent/DK2146713T3/da active
- 2008-04-16 EA EA200970968A patent/EA015503B1/ru not_active IP Right Cessation
- 2008-04-16 RS RS20120041A patent/RS52130B/en unknown
- 2008-04-16 MY MYPI20094365A patent/MY147207A/en unknown
- 2008-04-17 TW TW097113999A patent/TWI423800B/zh not_active IP Right Cessation
- 2008-04-17 JO JO2008184A patent/JO2861B1/en active
- 2008-04-18 CL CL2008001135A patent/CL2008001135A1/es unknown
- 2008-04-18 AR ARP080101599A patent/AR066105A1/es unknown
- 2008-04-18 UY UY31034A patent/UY31034A1/es not_active Application Discontinuation
-
2009
- 2009-10-05 US US12/573,322 patent/US9393236B2/en not_active Expired - Fee Related
- 2009-10-11 IL IL201447A patent/IL201447A/en not_active IP Right Cessation
- 2009-10-19 CO CO09116642A patent/CO6140028A2/es unknown
- 2009-11-10 MA MA32334A patent/MA31368B1/fr unknown
-
2010
- 2010-08-31 HK HK10108260.4A patent/HK1141724A1/xx not_active IP Right Cessation
-
2012
- 2012-01-26 CY CY20121100094T patent/CY1112282T1/el unknown
- 2012-02-07 HR HR20120130T patent/HRP20120130T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2011002955A1 (es) | Compuestos derivados de 3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il]octanonitrilo o heptanonitrilo o sus sales, como inhibidores de jak; procedimiento de preparacion; composicion farmaceutica que los comprende; utiles para el tratamiento de trastornos autoinmunes, cancer, entre otras enfermedades. | |
ECSP13012611A (es) | Derivados de pirazol-aminopirimidina como moduladores de la lrrk2 | |
UY30333A1 (es) | Uso de flibanserina para el tratamiento de trastornos posmenopausicos del deseo sexual | |
UY29899A1 (es) | Uso de flibanserina para el tratamiento de trastornos del deseo sexual premenopausicos | |
DOP2005000025A (es) | Compuestos de heteroaril- y fenilsulfamoilo sustituidos | |
CO6491058A2 (es) | Derivados de oxazina y su uso como inhibidores de bace para el tratamiento de trastornos neurológicos | |
CR11420A (es) | Moduladores de gpr40 bifenilo sustituidos | |
CY1112429T1 (el) | Υποκατεστημενα παραγωγα σουλφοναμιδιου | |
UY31351A1 (es) | (ciclopropilfenil)feniloxamidas, procedimiento para su preparación y su uso como medicamentos | |
ECSP088210A (es) | Bencimidazoles sustituidos y métodos de preparación | |
UY28757A1 (es) | Compuestos de pirazolina substituidos, su preparación y su uso como medicamentos | |
ECSP10010518A (es) | Hidroximetil pirrolidinas como agonistas del receptor adrenergico beta 3 | |
ECSP11011151A (es) | Compuestos purina | |
ECSP099722A (es) | Compuestos de pirido [2, 3-d] pirimidina-7-ona como inhibidores de pi3k-alfa para el tratamiento del cáncer | |
CL2012001031A1 (es) | Compuestos derivados de 2-oxo-1-pirrolidinil-imidazotiadiazol; composición farmacéutica que los comprende; útiles para el tratamiento de la epilepsia, transtornos neurológicos, entre otros. | |
AR061446A1 (es) | Utilizacion de la 1,7 -dimetilxantina para la fabricacion de un medicamento psicoanaleptico no ansiogeno destinado al tratamiento de un trastorno neuropsiquiatrico | |
PA8798401A1 (es) | Forma cristalina 1 de 2-((r)-2-metilpirrolidin-2-il)-1h-benzimidazol-4-carboxamida | |
PA8776601A1 (es) | Utilización de 4-ciclopropilmetoxi-n-(3,5-dicloro-1- oxido-piridin-4-il)-5(metoxi)piridin-2-carboxamida para el tratamiento de los traumatismos de la medula espinal | |
DE602008002598D1 (en) | Cyclohexylderivate | |
PA8776701A1 (es) | Utilización de 4-ciclopropilmetoxi-n-(3,5-dicloro-1-oxido-4-piridin-4-il)-5-(metoxi)piridin-2-carboxamida para el tratamiento de los traumatismos craneales. | |
PA8776801A1 (es) | Utilización de 4-ciclopropilmetoxi-n-(3,5-dicloro-1-oxido-piridin-4-il)-5-(metoxi)piridin-2-carboxamida para el tratamiento de trastornos motores asociados a la enfermedad de parkinson. | |
MX2009008040A (es) | Uso de arcillas para tratar la enfermedad celiaca. | |
CO6680616A2 (es) | Compuestos de tiofeno 2.3.5- trisustituidos y usos de los mismos | |
UY30869A1 (es) | Proceso para la preparacion de heteroaril sulfamatos benzo-fusionados | |
HN2012000132A (es) | Derivados de oxazina y su uso como inhibidores de bace para el tratamiento de trastornos neurologicos |